Macuject
Gihan Samarasinghe is a Machine Learning and AI expert with extensive experience in leading projects and research across various organizations. Currently serving as the Machine Learning and AI Lead at Macuject since May 2022, Gihan spearheads R&D to create innovative software aimed at preventing blindness. Prior positions include Project Lead at Transport for NSW, Senior AI Engineer at Harrison.ai, and Team Lead at Lumachain, specializing in Computer Vision and Machine Learning solutions. Gihan has previously contributed to academia as a Lecturer and Postdoctoral Researcher at UNSW, focusing on machine learning applications in healthcare and environmental sciences, while also engaging in several impactful research initiatives and collaborations in medical imaging and analysis. Gihan holds a Ph.D. in Computer Science and Engineering from UNSW and a BSc in Computer Engineering from the University of Peradeniya.
This person is not in any teams
Macuject
Macuject is a clinician-driven digital health company created to end preventable blindness for tens of millions across the globe, starting with age-related macular degeneration (AMD); diabetic retinopathy, cataract and glaucoma will follow. Our innovative clinical decision support software is specifically designed to address both wet and dry forms of AMD, empowering healthcare professionals to make accurate and timely diagnoses, optimise treatment plans, and monitor disease progression more effectively. By harnessing the power of cutting-edge artificial intelligence and integrating seamlessly with existing medical infrastructure, our SaaS solutions enable early intervention and personalized care, dramatically improving patient outcomes and significantly reducing the social and economic burden of these blinding conditions. Macuject’s founder-CEO is Dr. Devinder Chauhan, a prominent Melbourne retinal specialist responsible for 8% of his state's AMD treatments. Leveraging his expertise and network, he has brought together a talented team of professionals with diverse backgrounds in commercial, technical and clinical development. Our collaborative team is dedicated to developing, refining, and promoting our ground-breaking products, ensuring both their clinical relevance and market adoption.